📰 Integrative Screening Process News
Page 2 - Integrative Screening Process News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Integrative Screening Process. Real-time updates on events, politics, business and more.
April 29, 2024
GOTHENBURG, SWEDEN / ACCESSWIRE / April 29, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, announced today that the Annual Report for 2023 is published on the company's website, www.irlab.se.IRLAB today has published the Annual Report...
February 29, 2024
GOTHENBURG, SWEDEN / ACCESSWIRE / February 29, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 29, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's ...
February 28, 2024
Gothenburg, Sweden, February 28, 2024 – IRLAB Therapeutics AB , a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will present at the...
February 28, 2024
GOTHENBURG, SWEDEN / ACCESSWIRE / February 28, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 28, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will present at th...
February 28, 2024
IRLAB to Present at the Bayes@Lund 2024 Conference in Lund, Sweden ...
February 27, 2024
27.02.2024 - GOTHENBURG, SWEDEN / ACCESSWIRE / February 27, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for ...
February 27, 2024
IRLAB to Present Clinical and Preclinical Data at the AD/PD(TM) 2024: ...
February 27, 2024
GOTHENBURG, SWEDEN / ACCESSWIRE / February 27, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will present two...
February 22, 2024
IRLAB has Completed a Successful End-of-Phase 2 Meeting with the FDA ...
February 22, 2024
GOTHENBURG, SWEDEN / ACCESSWIRE / February 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, 22 February 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's ...